BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1454 related articles for article (PubMed ID: 28244671)

  • 1. Prebiotic inulin-type fructans and galacto-oligosaccharides: definition, specificity, function, and application in gastrointestinal disorders.
    Wilson B; Whelan K
    J Gastroenterol Hepatol; 2017 Mar; 32 Suppl 1():64-68. PubMed ID: 28244671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered gastrointestinal microbiota in irritable bowel syndrome and its modification by diet: probiotics, prebiotics and the low FODMAP diet.
    Staudacher HM; Whelan K
    Proc Nutr Soc; 2016 Aug; 75(3):306-18. PubMed ID: 26908093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nutritional, microbiological and psychosocial implications of the low FODMAP diet.
    Staudacher HM
    J Gastroenterol Hepatol; 2017 Mar; 32 Suppl 1():16-19. PubMed ID: 28244658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. History of the low FODMAP diet.
    Gibson PR
    J Gastroenterol Hepatol; 2017 Mar; 32 Suppl 1():5-7. PubMed ID: 28244673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. When the low FODMAP diet does not work.
    Halmos EP
    J Gastroenterol Hepatol; 2017 Mar; 32 Suppl 1():69-72. PubMed ID: 28244666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does Fibre-fix provided to people with irritable bowel syndrome who are consuming a low FODMAP diet improve their gut health, gut microbiome, sleep and mental health? A double-blinded, randomised controlled trial.
    Yan R; Murphy M; Genoni A; Marlow E; Dunican IC; Lo J; Andrew L; Devine A; Christophersen CT
    BMJ Open Gastroenterol; 2020 Aug; 7(1):. PubMed ID: 32816830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Re-challenging FODMAPs: the low FODMAP diet phase two.
    Tuck C; Barrett J
    J Gastroenterol Hepatol; 2017 Mar; 32 Suppl 1():11-15. PubMed ID: 28244664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FODMAPs: food composition, defining cutoff values and international application.
    Varney J; Barrett J; Scarlata K; Catsos P; Gibson PR; Muir JG
    J Gastroenterol Hepatol; 2017 Mar; 32 Suppl 1():53-61. PubMed ID: 28244665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fermentable oligosaccharides, disaccharides, monosaccharides and polyols: role in irritable bowel syndrome.
    Tuck CJ; Muir JG; Barrett JS; Gibson PR
    Expert Rev Gastroenterol Hepatol; 2014 Sep; 8(7):819-34. PubMed ID: 24830318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How to institute the low-FODMAP diet.
    Barrett JS
    J Gastroenterol Hepatol; 2017 Mar; 32 Suppl 1():8-10. PubMed ID: 28244669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Food regulations: low FODMAP labeling and communication goals.
    Méance S; Giordano J; Chuang E; Schneider H
    J Gastroenterol Hepatol; 2017 Mar; 32 Suppl 1():62-63. PubMed ID: 28244659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The gut microbiome as a predictor of low fermentable oligosaccharides disaccharides monosaccharides and polyols diet efficacy in functional bowel disorders.
    Chumpitazi BP
    Curr Opin Gastroenterol; 2020 Mar; 36(2):147-154. PubMed ID: 31850930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dietary Fermentable Oligosaccharides, Disaccharides, Monosaccharides, and Polyols (FODMAPs) and Gastrointestinal Disease.
    Vakil N
    Nutr Clin Pract; 2018 Aug; 33(4):468-475. PubMed ID: 29870082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adapting the low FODMAP diet to special populations: infants and children.
    Iacovou M
    J Gastroenterol Hepatol; 2017 Mar; 32 Suppl 1():43-45. PubMed ID: 28244674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring Gut Microbiota Composition as an Indicator of Clinical Response to Dietary FODMAP Restriction in Patients with Irritable Bowel Syndrome.
    Valeur J; Småstuen MC; Knudsen T; Lied GA; Røseth AG
    Dig Dis Sci; 2018 Feb; 63(2):429-436. PubMed ID: 29302878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of the low-FODMAP diet in inflammatory bowel disease.
    Gibson PR
    J Gastroenterol Hepatol; 2017 Mar; 32 Suppl 1():40-42. PubMed ID: 28244679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Diet Low in FODMAPs Reduces Symptoms in Patients With Irritable Bowel Syndrome and A Probiotic Restores Bifidobacterium Species: A Randomized Controlled Trial.
    Staudacher HM; Lomer MCE; Farquharson FM; Louis P; Fava F; Franciosi E; Scholz M; Tuohy KM; Lindsay JO; Irving PM; Whelan K
    Gastroenterology; 2017 Oct; 153(4):936-947. PubMed ID: 28625832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Who should deliver the low FODMAP diet and what educational methods are optimal: a review.
    O'Keeffe M; Lomer MC
    J Gastroenterol Hepatol; 2017 Mar; 32 Suppl 1():23-26. PubMed ID: 28244661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The evidence base for efficacy of the low FODMAP diet in irritable bowel syndrome: is it ready for prime time as a first-line therapy?
    Gibson PR
    J Gastroenterol Hepatol; 2017 Mar; 32 Suppl 1():32-35. PubMed ID: 28244668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dietary intake of inulin-type fructans in active and inactive Crohn's disease and healthy controls: a case-control study.
    Anderson JL; Hedin CR; Benjamin JL; Koutsoumpas A; Ng SC; Hart AL; Forbes A; Stagg AJ; Lindsay JO; Whelan K
    J Crohns Colitis; 2015 Nov; 9(11):1024-31. PubMed ID: 26221003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 73.